Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the outlook for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering hope for more effective treatment options.